A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer | |
Shu, Yongqian; Lu, Zhihao; Zhang, Xiaotian; Liu, Wei; Liu, Tianshu; Hu, Bing; Li, Wei; Fan, Qingxia; Xu, Jianming; Xu, Nong | |
刊名 | GASTRIC CANCER |
2018 | |
卷号 | 21期号:5 |
关键词 | Stomach neoplasms Paclitaxel Capecitabine Cisplatin |
ISSN号 | 1436-3291 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3538143 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Shu, Yongqian,Lu, Zhihao,Zhang, Xiaotian,et al. A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer[J]. GASTRIC CANCER,2018,21(5). |
APA | Shu, Yongqian.,Lu, Zhihao.,Zhang, Xiaotian.,Liu, Wei.,Liu, Tianshu.,...&Shen, Lin.(2018).A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.GASTRIC CANCER,21(5). |
MLA | Shu, Yongqian,et al."A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer".GASTRIC CANCER 21.5(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论